# A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia

> **NCT03110315** · PHASE4 · COMPLETED · sponsor: **Theodore R. Brown, MD MPH** · enrollment: 36 (actual)

## Conditions studied

- Multiple Sclerosis
- Fatigue
- Insomnia

## Interventions

- **DRUG:** Suvorexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03110315
- **Lead sponsor:** Theodore R. Brown, MD MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-28
- **Primary completion:** 2022-03-21
- **Final completion:** 2022-03-21
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110315, "A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03110315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*